Medicine: Drug Trial Abandoned

Alarmed by continuing reports of undesirable side effects from the drug car-butamide, given by mouth for the relief of diabetes (TIME, Oct. 29), Indianapolis' Eli Lilly & Co. asked 2,900 doctors who have been testing it on 10,000 patients to abandon the trial. Most disturbing was a report that—at least in animals—car-butamide can cause liver damage which might be worse than the diabetes it is meant to control. Lilly was already experimenting with other promising drugs.

Kalamazoo's Upjohn Co. was quick to announce that tests with its antidiabetes drug, tolbutamide (Orinase) continued encouraging, with...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!